Press Release May 23, 2023 Interstitial Lung Diseases Pipeline Insight | Key Companies – Roche, Bayer, Insmed, Avalyn Pharma, PureTech Health, Novartis, Horizon, MediciNova, Endeavor BioMedicines, Pliant Therapeutics, and Others
Press Release May 23, 2023 Gastric Cancer Pipeline Insight | Key Companies – Eli Lilly and Company, Janssen Pharmaceutical, Hoffmann-La Roche, Novartis, Genentech, Exelixis, Bristol Myers Squibb, Pieris Pharmaceuticals and Other
Press Release May 23, 2023 Acute Myeloid Leukemia Pipeline Insight | Key Companies – Takeda, Bristol-Myers Squibb, Allogene Therapeutics, Novartis, Janssen, Teva Pharma, Bristol-Myers Squibb, and Others
Press Release May 23, 2023 Advanced Hepatocellular Carcinoma Pipeline Insight | Key Companies – Innovent Biologics, Akesobio, BeiGene, Zai Lab (Shanghai) Co., Geneos Therapeutics, Adaptimmune Therapeutics, CStone Pharmaceuticals
Press Release May 23, 2023 Advanced Gastric Carcinoma Pipeline 2023 | Key Companies – BeiGene, Bristol-Myers Squibb, Hanmi Pharmaceutical, AstraZeneca, Genentech, Seagen Inc, Bicycle Tx Limited, Vedanta Biosciences Inc, and othe
Press Release May 23, 2023 Advanced Endometrial Cancer Pipeline 2023 | Key Companies – Incyte Corporation, Zymeworks Inc., AstraZeneca, Eli Lilly and Company, Pfizer, Genentech, NETRIS Pharma, Takeda, and Others
Press Release May 23, 2023 Advanced Cervical Cancer Pipeline 2023 | Key Companies – AstraZeneca, GlaxoSmithKline, Advaxis, Bristol-Myers Squibb, Innovent Biologics, Shanghai Henlius Biotech, Genexine, Inc., Merck, and Others
Press Release May 23, 2023 Advanced Cancer Pain Management Pipeline Insight 2023 | Key Companies – Tetra Bio-Pharma, Medlab, Sorrento Therapeutics Inc, Pfizer, and Others
Press Release May 23, 2023 Adult-Onset Still Disease Pipeline and Clinical Trials 2023 | Key Companies – AB2 Bio Ltd., Cerecor, Roche, Swedish Orphan Biovitrum, and others